As per this study the Global Tumor Ablation Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of XX.X%.
Tumor ablation is a technique used for the minimal or noninvasive treatment of tumors commonly in liver, kidney, bone, and lung tumors. This technique is used to burn or freeze cancer with the help of needle probes. The technology used for the guidance of needle probes includes computed tomography (CT), ultrasound (US) or magnetic resonance imaging (MRI). Additionally, tumor ablation has application in various cancer types which includes liver cancer, breast cancer, lung cancer, and prostate cancer.
The increasing prevalence of cancer coupled with the rising demand for minimally invasive surgeries such as radiofrequency ablation is driving the market growth. Additionally, rising expenditure in the healthcare industry along with the increasing awareness among people about the tumor ablation technique is further fuelling market growth. On the other hand, the high cost of tumor ablation technique may hamper the market growth. Whereas, ongoing R&D for tumor ablation techniques and favorable governmental initiatives for cancer treatment are expected to offer an opportunity during the forecast period.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis, and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of tumor ablation.
The broad tumor ablation market has been sub-grouped into technology, treatment, and application. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
- Irreversible Electroporation
- Other Technologies
- Liver Cancer
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Other Cancer
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for tumor ablation in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Europe Tumor Ablation Market By Revenue (USD MN)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the tumor ablation market include AngioDynamics, Biotronik, Boston Scientific Corporation, EDAP TMS, ERBE Elektromedizin GmbH, Galil Medical, Inc., HealthTronics, Inc., Medtronic, Mermaid Medical, Misonix Inc., NeuWave Medical, Inc., and SonaCare Medical LLC. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.